EnglishErgebnisse aus der epidemiologischen Forschung
Publikationen im Zusammenhang mit COVID-19
Evidenzgenerierung durch nationale und globale Netzwerke
Die SARS-CoV-2 Pandemie hat Patienten mit rheumatologischen Erkrankungen stark verunsichert, da unklar ist, ob sie aufgrund ihrer immunvermittelten Erkrankung oder ihrer immun-modulierenden Therapie besonders gefährdet sind, bei einer COVID-19 Erkrankung einen schweren Verlauf zu erleiden.
Auch für die behandelnden Rheumatologen war diese Situation schwierig, da abgewogen werden musste, zwischen dem Risiko einer aufflammenden Erkrankung mit all ihren negativen Folgen für den Patienten und dem Risiko eines möglicherweise zu stark geschwächten Immunsystems. Therapieentscheidungen mussten ohne vergleichbare Erfahrungswerte und nicht Daten basiert erfolgen.
Angesichts dieser Situation hat sich die Arbeitsgruppe Pharmakoepidemiologie am Aufbau des deutschen und des europäischen COVID-19-Registers beteiligt, in die Patienten mit entzündlich-rheumatischer Erkrankung und einer SARS-CoV-2-Infektion eingeschlossen werden. Stand August 2020 sind 2.561 Patienten im europäischen (4293 global) und 373 Patienten im deutschen Register erfasst. Durch Mitwirkung in den Steuerungsgruppen und der Datenauswertung innerhalb der Register ist der Programmbereich Epidemiologie wesentlich an der Erforschung neuer Erkenntnisse über die besondere Situation von Patienten mit Autoimmunerkrankungen unter Immunsuppression beteiligt.
Die Arbeitsgruppe Kinderrheumatologie und Versorgungsforschung hat die Kerndokumentation rheumakranker Kinder und Jugendlicher um zwei Zusatzmodule zur Erfassung von SARS-CoV-2-Infektionen und des SARS-CoV-2-assoziierten Hyperinflammationssyndroms (MIS C für „multisystem inflammatory syndrome in children“) erweitert. Im August waren bundesweit 15 Kinder mit rheumatischen Grunderkrankungen und SARS-CoV-2-Infektionen sowie 4 mit MIS-C gemeldet. Weitere 4 Fälle mit SARS-CoV-2-Infektionen wurden über das BiKeR-Register und das Register der Deutschen Gesellschaft für pädiatrische Infektiologie erfasst, mit denen kooperiert wird. Gemeinsam mit den Universitäten Potsdam und Ulm hat das DRFZ darüber hinaus das Forschungsprojekt Kick Covid eingeworben, in dem langfristige Auswirkungen der COVID-19-Pandemie auf das Wohlbefinden und die Gesundheitsversorgung von Kindern mit chronischen Krankheiten, die mit erhöhtem Risiko für schwere COVID-19 Verläufe einhergehen, und ihren Familien analysiert wird.
Ansprechpartner im DRFZ:
PD Dr. med. Anja Strangfeld – AG Pharmakoepidemiologie, PD Dr. med. Anne Regierer – AG Registerforschung in der Rheumatologie, Prof. Dr. med. Kirsten Minden – AG Kinder- und Jugendrheumatologie
Publikationen aus dem Programmbereich Epidemiologie
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries. Hasseli R, Hanses F, Stecher M, Specker C, Weise T, Borgmann S, Hasselberger M, Hertenstein B, Hower M, Hoyer BF, Koll C, Krause A, von Lilienfeld-Toal M, Lorenz HM, Merle U, Nunes de Miranda SM, Pletz MW, Regierer AC, Richter JG, Rieg S, Roemmele C, Ruethrich MM, Schmeiser T, Schulze-Koops H, Strangfeld A, Vehreschild MJGT, Voit F, Voll RE, Vehreschild JJ, Müller-Ladner U, Pfeil A. Front Med (Lausanne). 2024 Mar 6;11:1332716. doi: 10.3389/fmed.2024.1332716. eCollection 2024. PMID: 38510457 Free PMC article.
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry. Yazdany J, Ware A, Wallace ZS, Bhana S, Grainger R, Hachulla E, Richez C, Cacoub P, Hausmann JS, Liew JW, Sirotich E, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Ribeiro SLE, Al-Emadi S, Hasseli R, Müller-Ladner U, Specker C, Schulze-Koops H, Bernardes M, Fraga VM, Rodrigues AM, Sparks JA, Ljung L, Di Giuseppe D, Tidblad L, Wise L, Duarte-García A, Ugarte-Gil MF, Colunga-Pedraza IJ, Martínez-Martínez MU, Alpizar-Rodriguez D, Xavier RM, Isnardi CA, Pera M, Pons-Estel G, Izadi Z, Gianfrancesco MA, Carrara G, Scirè CA, Zanetti A, Machado PM. Arthritis Care Res (Hoboken). 2024 Feb;76(2):274-287. doi: 10.1002/acr.25220. Epub 2023 Nov 7. PMID: 37643903
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry” by Rosenbaum et al. Hyrich KL, Schäfer M, Strangfeld A, Carmona L, Gossec L, Mateus EF, Lawson-Tovey S, Gianfrancesco M, Robinson PC, Yazdany J, Machado PM. Ann Rheum Dis. 2023 Jun;82(6):e139. doi: 10.1136/annrheumdis-2021-220613. Epub 2021 May 13. PMID: 33985941 No abstract available.
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry” by Mulhearn et al. Schäfer M, Strangfeld A, Hyrich KL, Carmona L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Gossec L, Robinson PC, Yazdany J, Machado PM. Ann Rheum Dis. 2023 May;82(5):e116. doi: 10.1136/annrheumdis-2021-220134. Epub 2021 Mar 1. PMID: 33648957 No abstract available.
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers. Machado PM, Schäfer M, Strangfeld A, Gossec L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Carmona L, Hyrich KL, Robinson PC, Yazdany J. Ann Rheum Dis. 2023 May;82(5):e114. doi: 10.1136/annrheumdis-2021-220058. Epub 2021 Feb 18. PMID: 33602795 No abstract available.
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases. Hasseli R, Richter JG, Hoyer BF, Lorenz HM, Pfeil A, Regierer AC, Schmeiser T, Strangfeld A, Voll RE, Krause A, Reckert S, Gräßler A, Saar P, Kapelle A, Backhaus M, Blank N, Henes J, Osiek S, Knothe A, Hoese G, Brandt-Jürgens J, Maltzahn A, Specker C, Müller-Ladner U, Schulze-Koops H; COVID-19 task force of the German Society of Rheumatology collaborators; COVID19-Rheuma.de collaborators. RMD Open. 2023 Apr;9(2):e002998. doi: 10.1136/rmdopen-2023-002998. PMID: 37068915 Free PMC article.
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH. Ann Rheum Dis. 2023 Feb 14:ard-2022-223499. doi: 10.1136/ard-2022-223499. Online ahead of print. PMID: 36787993
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients. Ten Hagen A, Hermann S, Habermann E, Frommert LM, Arumahandi de Silva AN, Scholz V, Ghannam K, Klotsche J, Zernicke J, Alexander T, Burmester GR, Albach FN, Biesen R. J Autoimmun. 2023 Feb;135:102996. doi: 10.1016/j.jaut.2023.102996. Epub 2023 Jan 9. PMID: 36642057 Free PMC article.
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance. Ugarte-Gil MF, Alarcón GS, Seet AM, Izadi Z, Montgomery AD, Duarte-García A, Gilbert EL, Valenzuela-Almada MO, Wise L, Sparks JA, Hsu TY, D’Silva KM, Patel NJ, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Wallace Z, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Arthritis Care Res (Hoboken). 2023 Jan;75(1):53-60. doi: 10.1002/acr.25039. Epub 2022 Dec 2. PMID: 36239292 Free PMC article.
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. Izadi Z, Gianfrancesco MA, Aguirre A, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Seet AM, Schmajuk G, Jacobsohn L, Katz P, Rush S, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ribeiro SLE, de Oliveira Marinho A, de Azevedo Valadares LD, Giuseppe DD, Hasseli R, Richter JG, Pfeil A, Schmeiser T, Isnardi CA, Reyes Torres AA, Alle G, Saurit V, Zanetti A, Carrara G, Labreuche J, Barnetche T, Herasse M, Plassart S, Santos MJ, Rodrigues AM, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Yazdany J; Global Rheumatology Alliance Registry. ACR Open Rheumatol. 2022 Oct;4(10):872-882. doi: 10.1002/acr2.11481. Epub 2022 Jul 22. PMID: 35869686 Free PMC article.
Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status. Maguire S, Al-Emadi S, Alba P, Aguiar MC, Lawati TA, Alle G, Bermas B, Bhana S, Branimir A, Bulina I, Clowse M, Cogo K, Colunga I, Cook C, Cortez KJ, Dao K, Gianfrancesco M, Gore-Massey M, Gossec L, Grainger R, Hausman J, Hsu TYT, Hyrich K, Isnardi C, Kawano Y, Kilding R, Kusevich DA, Lawson-Tovey S, Liew J, McCarthy E, Montgumery A, Moyano S, Nasir N, Padjen I, Papagoras C, Patel NJ, Pera M, Pisoni C, Pons-Estel G, Quiambao AL, Quintana R, Ruderman E, Sattui S, Savio V, Sciascia S, Sencarova M, Morales RS, Siddique F, Sirotich E, Sparks J, Strangfeld A, Sufka P, Tanner H, Tissera Y, Wallace Z, Werner ML, Wise L, Worthing AB, Zell J, Zepa J, Machado PM, Yazdany J, Robinson P, Conway R; COVID-19 Global Rheumatology Alliance. Rheumatology (Oxford). 2022 Sep 19:keac534. doi: 10.1093/rheumatology/keac534. Online ahead of print. PMID: 36124987
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Yeoh SA, Gianfrancesco M, Lawson-Tovey S, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Schäfer M, Richez C, Hachulla E, Holmqvist M, Scirè CA, Lorenz HM, Voll RE, Hasseli R, Jayatilleke A, Hsu TY, D’Silva KM, Pimentel-Quiroz VR, Vasquez Del Mercado M, Shinjo SK, Neto ETDR, Junior LFDR, de Oliveira E Silva Montandon AC, Pons-Estel GJ, Ornella S, D’Angelo Exeni ME, Velozo E, Jordan P, Sirotich E, Hausmann JS, Liew JW, Jacobsohn L, Gore-Massy M, Sufka P, Grainger R, Bhana S, Wallace Z, Robinson PC, Yazdany J, Machado PM; COVID-19 Global Rheumatology Alliance. RMD Open. 2022 Sep;8(2):e002508. doi: 10.1136/rmdopen-2022-002508. PMID: 36100295 Free PMC article.
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases. Kearsley-Fleet L, Chang ML, Lawson-Tovey S, Costello R, Fingerhutová Š, Švestková N, Belot A, Aeschlimann FA, Melki I, Koné-Paut I, Eulert S, Kallinich T, Berkun Y, Uziel Y, Raffeiner B, Oliveira Ramos F, Clemente D, Dackhammar C, Wulffraat NM, Waite H, Strangfeld A, Mateus EF, Machado PM; CARRA Registry Investigators; COVID-19 Global Pediatric Rheumatology Database Investigators, Natter M, Hyrich KL. Ann Rheum Dis. 2022 Jul;81(7):998-1005. doi: 10.1136/annrheumdis-2022-222241. Epub 2022 Mar 25. PMID: 35338032 Free PMC article.
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry. Lawson-Tovey S, Machado PM, Strangfeld A, Mateus E, Gossec L, Carmona L, Raffeiner B, Bulina I, Clemente D, Zepa J, Rodrigues AM, Mariette X, Hyrich KL; EULAR COVAX. RMD Open. 2022 Jul;8(2):e002322. doi: 10.1136/rmdopen-2022-002322. PMID: 35908834 Free PMC article.
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Ugarte-Gil MF, Alarcón GS, Izadi Z, Duarte-García A, Reátegui-Sokolova C, Clarke AE, Wise L, Pons-Estel GJ, Santos MJ, Bernatsky S, Ribeiro SLE, Al Emadi S, Sparks JA, Hsu TY, Patel NJ, Gilbert EL, Valenzuela-Almada MO, Jönsen A, Landolfi G, Fredi M, Goulenok T, Devaux M, Mariette X, Queyrel V, Romão VC, Sequeira G, Hasseli R, Hoyer B, Voll RE, Specker C, Baez R, Castro-Coello V, Maldonado Ficco H, Reis Neto ET, Ferreira GAA, Monticielo OAA, Sirotich E, Liew J, Hausmann J, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Jacobsohn L, Taylor T, Ja C, Strangfeld A, Mateus EF, Hyrich KL, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schäfer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Ann Rheum Dis. 2022 Jul;81(7):970-978. doi: 10.1136/annrheumdis-2021-221636. Epub 2022 Feb 16. PMID: 35172961 Free PMC article.
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases. Arumahandi de Silva AN, Frommert LM, Albach FN, Klotsche J, Scholz V, Jeworowski LM, Schwarz T, Ten Hagen A, Zernicke J, Corman VM, Drosten C, Burmester GR, Biesen R. Ann Rheum Dis. 2022 Jun;81(6):881-888. doi: 10.1136/annrheumdis-2021-221876. Epub 2022 Mar 14. PMID: 35288376 Free PMC article.
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Rodrigues A, Raffeiner B, Duarte C, Hachulla E, Veillard E, Strakova E, Burmester GR, Yardımcı GK, Gomez-Puerta JA, Zepa J, Kearsley-Fleet L, Trefond L, Cunha M, Mosca M, Cornalba M, Soubrier M, Roux N, Brocq O, Durez P, Conway R, Goulenok T, Bijlsma JW, McInnes IB, Mariette X. Ann Rheum Dis. 2022 May;81(5):695-709. doi: 10.1136/annrheumdis-2021-221490. Epub 2021 Dec 31. PMID: 34972811 Free PMC article.
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. Liew J, Gianfrancesco M, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Frãzao-Mateus E, Bulina I, Stafford F, Tufan A, Graver C, Yardımcı GK, Zepa J, Al Emadi S, Cook C, Abutiban F, Dey D, Katigbak G, Kaufman L, Kowalski E, Martínez-Martínez MU, Patel NJ, Reyes-Cordero G, Salido E, Smith E, Snow D, Sparks J, Wise L, Bhana S, Gore-Massy M, Grainger R, Hausmann J, Sirotich E, Sufka P, Wallace Z, Machado PM, Robinson PC, Yazdany J. RMD Open. 2022 Apr;8(1):e002187. doi: 10.1136/rmdopen-2021-002187. PMID: 35387864 Free PMC article.
Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring. Liefeldt L, Glander P, Klotsche J, Straub-Hohenbleicher H, Budde K, Eberspächer B, Friedersdorff F, Halleck F, Hambach P, Hofmann J, Koch N, Schmidt D, Schrezenmeier E, Seelow E, Weber U, Zukunft B, Eckardt KU, Choi M, Bachmann F, Waiser J. J Clin Med. 2022 Mar 18;11(6):1697. doi: 10.3390/jcm11061697. PMID: 35330022 Free PMC article.
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. Bermas BL, Gianfrancesco M, Tanner HL, Seet AM, Aguiar MC, Al Adhoubi NK, Al Emadi S, Cunha BM, Flood R, Kusevich DA, McCarthy EM, Patel NJ, Ruderman EM, Sattui SE, Sciascia S, Siddique F, Valenzuela-Almada MO, Wise LM, Worthing AB, Zell J, Bhana S, Costello W, Duarte-Garcia A, Grainger R, Gossec L, Hausmann JS, Hyrich K, Lawson-Tovey S, Liew JW, Sirotich E, Sparks JA, Sufka P, Wallace ZS, Machado PM, Strangfeld A, Clowse MEB, Yazdany J, Robinson PC. J Rheumatol. 2022 Jan;49(1):110-114. doi: 10.3899/jrheum.210480. Epub 2021 Sep 1. PMID: 34470798.
SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases. Lawson-Tovey S, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Raffeiner B, Yardımcı GK, Trefond L, Roux N, Rodrigues A, Papagoras C, Mateus EF, Mariette X, Machado PM. Ann Rheum Dis. 2022 Jan;81(1):145-150. doi: 10.1136/annrheumdis-2021-221217. Epub 2021 Sep 6. PMID: 34489305 No abstract available.
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination. Specker C, Aries P, Braun J, Burmester G, Fischer-Betz R, Hasseli R, Holle J, Hoyer BF, Iking-Konert C, Krause A, Krüger K, Krusche M, Leipe J, Lorenz HM, Moosig F, Schmale-Grede R, Schneider M, Strangfeld A, Voll R, Voormann A, Wagner U, Schulze-Koops H. Z Rheumatol. 2021 Dec;80(Suppl 2):33-48. doi: 10.1007/s00393-021-01055-7. Epub 2021 Sep 7. PMID: 34491403 Free PMC article. Review. No abstract available.
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD. Regierer AC, Hasseli R, Schäfer A, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schmeiser T, Schulze-Koops H, Strangfeld A, Voll RE, Specker C, Mueller-Ladner U.RMD Open. 2021 Oct;7(3):e001896. doi: 10.1136/rmdopen-2021-001896.PMID: 34670840.
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Strangfeld A, Schäfer A, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM; COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498.
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.Sattui SE, Conway R, Putman MS, Seet AM, Gianfrancesco MA, Beins K, Hill C, Liew D, Mackie SL, Mehta P, Neill L, Gomez G, Salinas MIH, Maldonado FN, Mariz HA, de Sousa Studart SA, Araujo NC, Knight A, Rozza D, Quartuccio L, Samson M, Bally S, Maria AT, Chazerain P, Hasseli R, Müller-Ladner U, Hoyer BF, Voll R, Torres RP, Luis M, Ribeirio SLE, Al-Emadi S, Sparks JA, Hsu TY, D’Silva KM, Patel NJ, Wise L, Gilbert E, Almada MV, Duarte-García A, Ugarte-Gil M, Jacobsohn L, Izadi Z, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Sirotich E, Hausmann JS, Sufka P, Bhana S, Liew JW, Grainger R, Machado PM, Wallace ZS, Yazdany J, Robinson PC; Global Rheumatology Alliance. Lancet Rheumatol. 2021 Dec;3(12):e855-e864. doi: 10.1016/S2665-9913(21)00316-7. Epub 2021 Nov 5. PMID: 34778843 Free PMC article.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D’Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Alliance (GRA). JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639. PMID: 34661663.
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. Hasseli R, Pfeil A, Hoyer BF, Lorenz HM, Regierer AC, Richter JG, Schmeiser T, Strangfeld A, Voll RE, Krause A, Schulze-Koops H, Müller-Ladner U, Specker C. Z Rheumatol. 2021 Sep;80(7):641-646. doi: 10.1007/s00393-021-01034-y. Epub 2021 Jul.
EULAR COVID-19 registry: lessons learnt and future considerations. Lawson-Tovey S, Strangfeld A, Hyrich KL, Carmona L, Rodrigues D, Gossec L, Mateus EF, Machado PM. Ann Rheum Dis. 2021 Sep;80(9):1110-1115. doi: 10.1136/annrheumdis-2021-220319. Epub 2021 Apr 27.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D’Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer A, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Yazdany J; COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2021 Sep;80(9):1137-1146. doi: 10.1136/annrheumdis-2021-220418. Epub 2021 May 28.
Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany. Sengler C, Eulert S, Minden K, Niewerth M, Horneff G, Kuemmerle-Deschner J, Siemer C, Berendes R, Girschick H, Hühn R, Borte M, Hospach A, Emminger W, Armann J, Klein A, Kallinich T. RMD Open. 2021 Jul;7(2):e001687. doi: 10.1136/rmdopen-2021-001687. PMID: 34312307.
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry” by Mulhearn et al. Schäfer A, Strangfeld A, Hyrich KL, Carmona L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Gossec L, Robinson PC, Yazdany J, Machado PM. Ann Rheum Dis. 2021 Mar 1:annrheumdis-2021-220134. doi: 10.1136/annrheumdis-2021-220134. Online ahead of print.
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. Hasseli R, Mueller-Ladner U, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schäfer A, Schmeiser T, Strangfeld A, Schulze-Koops H, Voll RE, Specker C, Regierer AC. RMD Open. 2021 Jan;7(1):e001464. doi: 10.1136/rmdopen-2020-001464.
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. Hasseli R, Müller-Ladner U, Schmeiser T, Hoyer B, Krause A, Lorenz HM, Regierer AC, Richter JG, Strangfeld A, Voll RE, Pfeil A, Schulze-Koops H, Specker C. RMD Open 2020:6:e001332. doi:10.1136/rmdopen-2020-001332.
[COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].Janda A, Schuetz C, Heeg M, Minden K, Hedrich CM, Kallinich T, Hinze C, Schulz A, Speth F.Z Rheumatol. 2020 Aug 18:1-8. doi: 10.1007/s00393-020-00854-8. Online ahead of print.
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC; COVID-19 Global Rheumatology Alliance.Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871.
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J; COVID-19 Global Rheumatology Alliance Steering Committee.Lancet Rheumatol. 2020 May;2(5):e250-e253. doi: 10.1016/S2665-9913(20)30095-3.